C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 209/14 (2006.01) A61K 31/4045 (2006.01) A61P 9/06 (2006.01)
Patent
CA 2732513
Disclosed is bucindolol substantially free of its R-stereoisomer. Also disclosed are pharmaceutical compositions that include bucindolol substantially free of its R-stereoisomer or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. Also disclosed are methods of treating a patient that involve administering to the patient a therapeutically effective amount of a composition of the present invention. Formula (I).
L'invention porte sur du bucindolol pratiquement exempt de son stéréoisomère R. De plus, l'invention porte sur des compositions pharmaceutiques qui comprennent du bucindolol pratiquement exempt de son stéréoisomère R ou un sel pharmaceutiquement acceptable de celui-ci et un véhicule pharmaceutiquement acceptable. L'invention porte également sur des méthodes de traitement d'un patient qui comprennent l'administration au patient d'une quantité thérapeutiquement efficace d'une composition de la présente invention. Formule (I).
Bristow Michael R.
Port Jonathan D.
Arca Biopharma Inc.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Methods and compositions involving (s)-bucindolol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions involving (s)-bucindolol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions involving (s)-bucindolol will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1435874